Medication-Assisted Treatment Lowers Overdose in Corrections
Introduction
From a public-health perspective, correctional systems across the United States face growing pressure to improve health outcomes, reduce recidivism, and control rising healthcare and operational costs. As a result, opioid use disorder (OUD) sits at the center of these challenges.Notably, justice-involved populations experience some of the highest rates of OUD; however, they have historically had limited access to evidence-based treatment. As a result, Medication-Assisted Treatment more accurately referred to as Medication for Opioid Use Disorder (MOUD) has emerged as one of the most effective interventions available.
When implemented correctly, MAT in correctional settings does more than improve individual health. In fact, it also reduces overdose deaths after release, lowers rates of rearrest and reincarceration, and, over time, decreases long-term costs for correctional systems, healthcare providers, and communities. In this context, at DevotedDOc, we view correctional MAT not as an optional program, but rather as responsible, cost-effective medical care grounded in evidence. [1][2]
The Scope of Opioid Use Disorder in Corrections
Substance use disorders are highly prevalent in jails and prisons. Estimates consistently show that nearly two-thirds of people in jail meet criteria for a substance use disorder, with opioids playing a major role in overdose deaths and repeated justice involvement. Despite this burden, only a small percentage of incarcerated individuals historically received MOUD. [1][3]
This treatment gap has predictable consequences: unmanaged withdrawal, relapse after release, emergency healthcare utilization, and repeated incarceration. Correctional MAT programs directly address these drivers by treating OUD as the chronic medical condition it is. [2][3]
What MAT in Corrections Actually Includes
In practice, evidence-based correctional MAT programs provide FDA-approved medications such as buprenorphine, methadone, or naltrexone under licensed medical supervision. In addition, medication is combined with ongoing clinical monitoring and, when available, behavioral health support. Crucially, effective programs prioritize continuity of care beyond incarceration. [3][4]
MAT is not a short-term detox or disciplinary tool. It is long-term medical treatment designed to stabilize individuals, reduce harm, and support recovery. [4][5]
Reducing Overdose Deaths After Release
The Post-Release Overdose Crisis
Notably, people leaving jail or prison face an overdose risk that is 10 to 40 times higher than that of the general population. Moreover, the first two weeks after release are especially dangerous, with mortality risk exceeding 100 times baseline levels. As a result, reduced opioid tolerance, combined with relapse and a lack of medical follow-up, drives this risk.[6][7]
How MAT Saves Lives
Accordingly, correctional MAT programs that start and continue MOUD dramatically reduce post-release overdose deaths. According to available research, access to MOUD can reduce overdose mortality after release by up to 75%; moreover, it can lower all-cause mortality by as much as 85%. These are among the strongest outcome improvements seen in correctional health interventions. [7][8]
In this context, by maintaining opioid tolerance in a controlled, medically supervised way, MAT provides a critical protective effect during reentry.[6][8]
Reducing Recidivism Through Medical Stabilization
Untreated OUD Drives Reoffending
As a result, relapse, withdrawal, and cravings contribute directly to behaviors that lead to rearrest, including illicit drug use, probation violations, and survival-driven offenses. Consequently, when opioid use disorder is untreated, reincarceration becomes more likely, often within months of release. [1][9]
MAT Improves Justice Outcomes
Correctional MAT programs consistently show reductions in recidivism. Individuals who receive and continue MOUD are more likely to remain engaged in treatment, comply with supervision requirements, and avoid rearrest. Consequently, stabilization allows people to focus on housing, employment, and family reintegration rather than withdrawal and cravings. [2][9]
The Cost Impact of MAT in Corrections
Untreated OUD drives significant costs across systems:
- Emergency department visits and hospitalizations
- Withdrawal-related medical emergencies in custody
- Reincarceration and court involvement
- Public safety and law enforcement costs
These costs far exceed the expense of providing evidence-based treatment. [1][10]
MAT as a Cost-Effective Intervention
Accordingly, multiple analyses show that correctional MAT programs reduce overall system costs over time. Savings are realized through:
- Fewer medical emergencies
- Reduced use of crisis services
- Lower reincarceration rates
- Improved post-release stability
From a fiscal perspective, MAT is an investment that reduces downstream spending. [8][10]
Operational Benefits for Correctional Facilities
Correctional leaders often focus on day-to-day operations. MAT programs provide tangible operational benefits:
- Fewer withdrawal-related incidents
- Improved facility safety and stability
- Reduced strain on medical staff
- Clearer medical protocols and documentation
Facilities that implement MAT frequently report smoother operations and fewer disruptions linked to unmanaged withdrawal. [1][4]
Addressing Common Budget and Policy Concerns
“MAT Is Too Expensive”
Although medication and staffing require upfront funding, over time the long-term cost savings from reduced emergency care and reincarceration consistently outweigh the initial expenses.[8][10]
“We Can’t Staff It”
In this context, physician-led telemedicine allows facilities to implement MAT without expanding on-site specialist staffing, making programs scalable and predictable. [2][11]
“It’s Not a Correctional Responsibility”
Accordingly, federal guidance and court decisions increasingly recognize MOUD as medically necessary care. Therefore, providing MAT aligns correctional systems with healthcare standards and reduces legal risk.[1][9]
The Role of Telemedicine in Cost-Effective MAT
Telemedicine addiction treatment (tele-MOUD) strengthens the cost and outcome benefits of MAT by:
- Expanding access to licensed physicians
- Reducing transportation and security costs
- Supporting continuity after release
- Scaling programs across multiple facilities
In this context, telemedicine allows correctional systems to deliver high-quality care while controlling costs and operational burden. [2][11]
How DevotedDOc Supports High-Value Correctional MAT
DevotedDOc provides physician-led, telemedicine-based addiction treatment designed to maximize both clinical outcomes and cost efficiency. Our model supports:
First and foremost, licensed physician supervision
In addition, buprenorphine-based MOUD
Moreover, telemedicine care during custody and reentry
As well as continuity of care beyond release
Finally, collaboration with correctional and reentry partners
We focus on measurable outcomes: fewer overdoses, lower recidivism, and sustainable program design. [2][11]
Public Health and Community Impact
Correctional MAT programs extend benefits beyond facility walls. Reduced overdose deaths, lower reincarceration rates, and improved stability contribute to safer communities and lower public healthcare costs. Accordingly, MAT in corrections is not only a correctional strategy but also a public health intervention.[6][8][10]
The Evidence Is Clear
Importantly, national organizations including SAMHSA, NIDA, and the National Sheriff’s Association consistently support correctional MAT as a best practice. Moreover, the data clearly show that MOUD reduces mortality, improves outcomes, and lowers costs when it is rolled out with continuity and proper medical supervision.[1][3][11]
Conclusion
Medication-Assisted Treatment in corrections works. It saves lives, reduces recidivism, and lowers long-term costs. Also, correctional systems that invest in evidence-based MAT programs are not adding complexity; they are addressing one of the most expensive and deadly drivers of repeat incarceration.
When MOUD is delivered as continuous, physician-led care, the benefits are clear for individuals, institutions, and communities alike. [2][8][10]
Call to Action: Partner or Refer
For facilities and organizations, DevotedDOc also supports correctional systems, courts, re-entry nonprofits, and public health stakeholders with physician-led MOUD models and scalable continuity workflows.
For families and supporters: If you want to help someone start treatment, you can support access directly through DevotedDOc’s donation pathway:
Medically Reviewed By Dr.
References
- National Sheriff’s Association. Jail-Based Medication-Assisted Treatment.
- Substance Abuse and Mental Health Services Administration (SAMHSA). Breaking the Cycle: MAT in the Criminal Justice System.
- National Institute on Drug Abuse (NIDA). Effective Treatments for Opioid Addiction.
- National Council for Mental Wellbeing. MAT for OUD in Jails and Prisons Toolkit.
- World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence.
- Addiction Science & Clinical Practice. Post-Release Opioid-Related Overdose Risk.
- American Civil Liberties Union. Over-Jailed and Un-Treated.
- JAMA Network Open. Trends in Buprenorphine Use in U.S. Jails and Prisons.
- Bureau of Justice Assistance / DOJ. Medication-Assisted Treatment in the Criminal Justice System.
- Centers for Disease Control and Prevention (CDC). Evidence-Based Strategies for Preventing Opioid Overdose.
- SAMHSA. Telehealth for the Treatment of Substance Use Disorders.
